LINC00944

Across TCGA pan-cancer cohorts, LINC00944 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC00944 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher LINC00944 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC00944 expression acts as an unfavorable survival marker, although some lineages such as SKCM and READ show a favorable association.

SKCM, KICH, and KIRC are the cancer types where LINC00944 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	All	0.685	0.549	<.001	110	view →
KICH	OS	Median	II,III,IV	0.565	0.964	<.001	103	view →
KIRC	OS	Tertile	All	0.529	0.710	<.001	90	view →
UVM	DFS	Quartile	All	0.268	0.711	<.001	65	view →
READ	OS	Quartile	All	0.925	0.563	<.001	62	view →
LUSC	DFS	Median	II,III,IV	0.293	0.509	<.001	54	view →
MESO	DFS	Quartile	All	0.248	0.552	.001	39	view →
LAML	DFS	Quartile	All	0.441	0.703	.007	36	view →
UCEC	DFS	Tertile	All	0.789	0.876	.009	20	view →
SARC	DFS	Quartile	All	0.413	0.689	.012	20	view →
THCA	DFS	Median	IV	0.954	0.488	.005	14	view →
BLCA	OS	Tertile	IV	0.723	0.477	.012	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC00944–SKCM (DFS)

Open the SKCM breakdown →